This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd., Beijing University of Technology. Active years: 2025-2026.
Company Filing History:

Years Active: 2025-2026
Title: Innovations and Contributions of YuQing Ma
Introduction
YuQing Ma is a prominent inventor based in Beijing, China. He has made significant contributions to the fields of chemical and biological engineering. With a total of 3 patents, his work focuses on improving the stability and efficiency of mRNA as well as enhancing urban sewage treatment processes.
Latest Patents
YuQing Ma's latest patents include a ribose-modified cap analog and a device and method for treating urban domestic sewage. The ribose-modified cap analog aims to improve the stability of mRNA and its translation efficiency. This innovation is crucial in the technical field of chemical and biological engineering. The second patent addresses urban domestic sewage treatment through a two-stage combined process of partial denitrification-anammox. This method effectively removes nitrogen from sewage without the need for an external carbon source, thereby enhancing nitrogen removal efficiency.
Career Highlights
Throughout his career, YuQing Ma has worked with notable institutions such as Beijing University of Technology and Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. His experience in these organizations has contributed to his expertise in the field of environmental engineering and biotechnology.
Collaborations
YuQing Ma has collaborated with several professionals, including XiaoDi Li and Wen Wang. These collaborations have further enriched his research and innovations.
Conclusion
YuQing Ma's contributions to the fields of chemical and biological engineering are noteworthy. His patents reflect a commitment to advancing technology in mRNA stability and urban sewage treatment. His work continues to impact these critical areas positively.